Yahoo!
My Yahoo!
Mail
Sign In
[New User?
Sign Up
]
Finance Home
|
Help
Wednesday, February 10, 2010, 3:06am EST - Canadian Markets open in 6 hours and 24 minutes.
To create a watchlist or portfolio of shares,
Sign-in
or
Register
Finance Home
Investing
Volume Leaders
Local Markets
US Markets
International Markets
Advances & Declines
ETFs
Income Trust News
News & Opinion
Markets
Industry
RSS-My Yahoo!
Personal Finance
Banking & Budgeting
Calculators
Insurance
Retirement
Taxes
My Portfolios
Sign In to Create/Edit My Portfolios
Get Quotes
Symbol Lookup
Exchanges
Elan Corp. plc (ELN)
On Feb 9:
7.07 USD
0.00 (0.00%)
MORE ON ELN
Quotes
Summary
Options
Historical Prices
Charts
Interactive
Basic Chart
Technical Chart
News & Info
Headlines
Company Events
Company
Profile
Key Statistics
SEC Filings
Competitors
Industry
Analyst Coverage
Analyst Opinion
Analyst Estimates
Research Reports
Star Analysts
Ownership
Major Holders
Insider Trans.
Insider Roster
Financials
Income Statement
Balance Sheets
Cash Flow
ELAN CP PLC ADR
(NYSE:ELN) Delayed quote data
Last Trade:
7.07 USD
Trade Time:
Feb 9
Change:
0.00 (0.00%)
Prev Close:
7.07
Open:
N/A
Bid:
N/A
Ask:
N/A
1y Target Est:
8.23
Day's Range:
N/A - N/A
52wk Range:
4.61 - 8.59
Volume:
0
Avg Vol
(3m)
:
2,737,700
Market Cap:
3.48B
P/E
(ttm)
:
66.70
EPS
(ttm)
:
0.11
Div & Yield:
N/A (N/A%)
1d
5d
3m
6m
1y
2y
5y
max
Free Annual Reports
Add ELN to Portfolio
Download Data
HEADLINES
Elan posts loss; sees adjusted '10 operating net
at MarketWatch
(Wed 2:26am)
Elan Reports Fourth Quarter and Full-Year 2009 Financial Results
Business Wire
(Wed 2:00am)
[$$] Earnings watch
at The Wall Street Journal Online
(Tue 7:35pm)
Biogen Beats & Guides Higher
Zacks.com
(Tue 4:18pm)
Biogen reports higher profit, raises forecast
at MarketWatch
(Tue 1:10pm)
UPDATE - Biogen 4th-qtr profit up, outlook tops estimates
at Reuters
(Tue 11:32am)
[$$] Tysabri Boosts Biogen Earnings
at The Wall Street Journal Online
(Tue 10:38am)
Biogen 4Q profit grows 48 percent on Tysabri sales
AP
(Tue 9:22am)
UPDATE - US warns of risk rise with more Tysabri infusions
at Reuters
(Fri, Feb 5)
FDA warns of brain risks with frequent Tysabri use
AP
(Fri, Feb 5)
7 Reasons to Worry About Next Week
at Motley Fool
(Thu, Feb 4)
More Headlines for ELN...
ANALYST
EPS Est (next year)
(Dec-09)
:
-0.51
EPS Est (in 2 years)
(Dec-10)
:
-0.21
Avg Rec (current)*:
3.5
PEG Ratio:
N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion
-
Estimates
BUSINESS SUMMARY
Elan Corporation, plc operates as a neuroscience-based biotechnology company primarily in Ireland and the United States. It operates in two segments, Biopharmaceuticals and Elan Drug Technologies (EDT).
Full Company Profile
Add to Portfolio
Email to a Friend
Get
Summary
for Another Symbol:
Symbol Lookup
Latest News
Canadian Indices